MEDICINA
Departamento
University of Szeged
Szeged, HungríaPublicaciones en colaboración con investigadores/as de University of Szeged (13)
2023
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
2021
-
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
Nature Communications, Vol. 12, Núm. 1
-
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085
-
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
Scientific Reports, Vol. 11, Núm. 1
2020
-
IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases
Scientific Reports, Vol. 10, Núm. 1
-
Standardization procedure for flow cytometry data harmonization in prospective multicenter studies
Scientific Reports, Vol. 10, Núm. 1
2017
-
Transancestral mapping and genetic load in systemic lupus erythematosus
Nature Communications, Vol. 8
2016
-
Off-label use of rituximab for systemic lupus erythematosus in Europe
Lupus Science and Medicine, Vol. 3, Núm. 1
2015
-
PXK locus in systemic lupus erythematosus: Fine mapping and functional analysis reveals novel susceptibility gene ABHD6
Annals of the Rheumatic Diseases, Vol. 74, Núm. 3
2012
-
Fine mapping and conditional analysis identify a new mutation in the autoimmunity susceptibility gene BLK that leads to reduced half-life of the BLK protein
Annals of the Rheumatic Diseases, Vol. 71, Núm. 7, pp. 1219-1226
2010
-
A 3′-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus
Arthritis and Rheumatism, Vol. 62, Núm. 11, pp. 3404-3414
2004
-
Continuing outcomes relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene
Journal of the National Cancer Institute, Vol. 96, Núm. 23, pp. 1751-1761